@article{856c2ba373954921971c7990905ccaa0,
title = "The uphill battle facing antiobesity drugs",
author = "M. Daubresse and Alexander, {G. C.}",
note = "Funding Information: GCA is supported by the Agency for Healthcare Research and Quality (RO1 HS0189960) and the National Heart, Lung and Blood Institute (R01HL107345). The funding sources had no role in the design and conduct of the study, analysis or interpretation of the data and preparation or final approval of the manuscript before publication. The statements, findings, conclusions, views and opinions contained and expressed in this article are based in part on data obtained under license from the following IMS Health Incorporated information service(s): National Prescription Audit (2011–2013). The statements, findings, conclusions, views and opinions contained and expressed herein are not necessarily those of IMS Health Incorporated or any of its affiliated or subsidiary entities.",
year = "2015",
month = mar,
day = "12",
doi = "10.1038/ijo.2014.169",
language = "English (US)",
volume = "39",
pages = "377--378",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "Nature Publishing Group",
number = "3",
}